己酮可可碱注射液在短暂性脑缺血发作患者中的应用效果

Abstract
Figure/Table
References (19)
Related Citation (15)

Download: PDF (550 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application effect of Pentoxifylline Injection on transient ischemic attack (TIA). Methods A total of 94 TIA patients admitted to Wuchang Hospital Affiliated to Wuhan University of Science and Technology from May 2018 to May 2020 were selected as the research subjects, and they were divided into control group and experimental group by lottery, with 47 patients in each group. Patients in the control group were given routine TIA attack treatment, while patients in the experimental group were additionally treated with Pentoxifylline Injection on the basis of the contrpl group. The clinical efficacy, cerebral blood flow parameters (the average blood flow [Qmean], maximum flow rate [Vmax], minimum velocity [Vmin]), CT perfusion imaging parameters (mean traansit time [MTT], time to peak [TTP], cerebral blood volume [CBV], cerebral blood flow [CBF]), vascular endothelial function (vascular endothelial growth factor [VEGF], vascular endothelin-1 [ET-1], nitric oxide [NO]) before and after treatment, adverse reactions, recurrence rate of TIA, incidence of cerebral infarction of two groups were conpared. Results The total effective rate in experimental group was higher than that in control group, and the difference was statistically significant (P<0.05). After treatment, Qmean, Vmax and Vmin in the experimental group were higher than those in the control group, and the differences were statistically significant (P<0.05). After treatment, MTT and TTP of the experimental group were lower than those of the control group, while CBV and CBF were higher than those of the control group, the differences were statistically significant (P<0.05). After treatment, VEGF and ET-1 in experimental group were lower than those in control group, and NO was higher than that in control group, the differences were statistically significant (P<0.05). The recurrence rate of TIA and incidence of cerebral infarction in the experimental group were lower than those in the control group, the differences were statistically significant (P<0.05). There was no statistically significant difference in the total incidence of adverse reactions between the two groups (P>0.05). Conclusion Pentoxifylline Injection in the treatment of patients with transient ischemic attack can effectively enhance the effective rate of clinical treatment, significantly improve the cerebral blood supply and vascular endothelial function, and reduce the recurrence rate of transient ischemic attack and the incidence rate of cerebral infarction in patients, with less side effects.

Key words： Pentoxifylline Injection Transient ischemic attack Clinical efficacy Application effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YAN Jixi

Cite this article:

YAN Jixi. Application effect of Pentoxifylline Injection in patients with transient ischemic attack[J]. 中国当代医药, 2022, 29(19): 18-22.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I19/18

[1]	陆伟恒，曾惠权，冯小敏，等.易损颈动脉斑块强化他汀治疗与支架术治疗在TIA中的对照研究[J].河北医药，2018， 40（15）：2347-2349.
[2]	孙万飞，于淑倩，王双艳，等.阿司匹林、氯吡格雷不同联合阿托伐他汀钙治疗对短暂缺血性脑缺血发作患者住院期间复发进展率的影响[J].中国医院药学杂志，2020， 40（18）：1974-1978.
[3]	成天军，丁虹，邓志龙.己酮可可碱对创伤失血性休克大鼠心血管功能和血液流变学的影响[J].重庆医学，2020， 49（22）：3714-3719.
[4]	郭留芹.阿司匹林联合氯吡格雷治疗短暂性脑缺血发作临床效果观察[J].医药论坛杂志，2017，38（3）：157-158.
[5]	中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J].中华神经科杂志，2015，48（4）：258-273.
[6]	薛庆华，武能坤，李鹏，等.血栓通联合阿托伐他汀治疗对短暂性脑缺血发作患者颈动脉粥样硬化斑块、血脂及血流变的影响[J].中华中医药学刊，2018，36（4）：1014-1018.
[8]	饶华强.行血息风汤联合马来酸桂哌齐特注射液治疗短暂性脑缺血的效果观察[J].中国中医药科技，2019，26（1）：62-64.
[9]	李蓓，杨琳，高毅，等.己酮可可碱对核因子-κB受体活化因子配基诱导的牙龈间充质干细胞破骨细胞分化功能的抑制作用[J].中国临床药理学杂志，2021，37（14）：1823-1827.
[10]	吕华军，朱乐乐，何国栋.养血清脑丸联合硫酸氢氯吡格雷在短暂性脑缺血发作治疗中的临床疗效[J].中国药物与临床，2020，20（2）：240-241.
[11]	翁翔，吴云虎.清热解毒通络汤辅助治疗对热毒痰瘀互阻型前循环短暂性脑缺血发作患者预后及血管内皮功能的影响[J].现代中西医结合杂志，2020，29（23）：2536-2539，2561.
[12]	韩远远，李丹，李洪涛，等.强化瑞舒伐他汀钙联合氯吡格雷及阿司匹林对高危短暂性脑缺血发作患者临床效果评价[J].中风与神经疾病杂志，2020，37（8）：710-712.
[13]	徐文武，丁小强.脑心通联合瑞舒伐他汀治疗短暂性脑缺血发作临床观察[J].解放军医药杂志，2020，32（10）：84-87.
[7]	黄勇军，张艳丽，付彦，等.血浆CXCL12、sVCAM-1检测对短暂性脑缺血发作并发缺血性脑卒中的预测价值[J].山东医药，2018，58（45）：61-64.
[14]	付春丽，王孟坤，王俊海.替罗非班治疗高复发风险短暂性脑缺血发作疗效分析[J].中风与神经疾病杂志，2021， 38（6）：488-491.
[15]	陈诗莉，董清，王玲.行血祛风汤联合马来酸桂哌齐特注射液对TIA患者血液流变学和脑动脉血流的影响[J].中国中医药科技，2020，27（2）：277-279.
[16]	王彬成，鲁慧，崔宁宁，等.缺血预适应对短暂性脑缺血发作患者血管弹性与内皮功能损伤的影响[J].山东医药，2018，58（18）：61-63.
[17]	李险峰.定眩汤对短暂性脑缺血发作患者血管内皮功能及脑血流参数的影响研究[J].陕西中医，2018，39（8）：1022-1024.
[18]	李彩萍，涂玲，刘晓晴，等.低频电刺激对老年短暂性脑缺血发作患者的血管内皮功能的影响[J].中华物理医学与康复杂志，2003，25（6）：360-361.
[19]	付春丽，王孟坤，王俊海.替罗非班治疗高复发风险短暂性脑缺血发作疗效分析[J].中风与神经疾病杂志，2021， 38（6）：488-491.